ROHTO PHARMACEUTICAL CO.,LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,036 JPY | +2.50% |
|
+4.03% | +6.79% |
| Apr. 04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
| Apr. 04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
Evolution of the average Target Price on Rohto Pharmaceutical Co.,Ltd.
Price target over the last 5 years
History of analyst recommendation changes
9c41a8350a1c1c3c3712c74300aae9.XWbWmw2B35x1JMYrARrLtIljN5ajxVIAX_FC88FWJFw.Kiy_yH_0rNABEIJ6Q2P4w-YgfKfynRo5GaJvkZQaYCQEN6LDQMLtzBIQ_g~5050cafadae412dc21412d615a376f6e
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
3,036
JPY
Average target price
3,892
JPY
Spread / Average Target
+28.21%
High Price Target
4,500
JPY
Spread / Highest target
+48.22%
Low Price Target
3,370
JPY
Spread / Lowest Target
+11.00%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 4527 Stock
- Consensus Rohto Pharmaceutical Co.,Ltd.
